Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action.

导出 OA

翻译打印收藏纠错

作者： Bartolomeo,Lorenzati ^[1] ; Chiara,Zucco ^[2] ; Sara,Miglietta ^[3] ; Federico,Lamberti ^[4] ; Graziella,Bruno ^[5]

作者单位： Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. lorebato@gmail.com. ^[1] Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. chiara.zucco@gmail.it. ^[2] Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. sara.miglietta@libero.it. ^[3] Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. federicolam@libero.it. ^[4] Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy. graziella.bruno@unito.it. ^[5]

关键词 hypoglycemic drugs incretin mimetics incretin mimeticshypoglycemic drugs sulfonylureas thiazolidinediones

DOI 10.3390/ph3093005

PMID 27713388

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交